-
Signature
-
Marta Woods by Power of Attorney
-
Issuer symbol
-
LRCX
-
Transactions as of
-
20 Feb 2025
-
Net transactions value
-
-$9,907,200
-
Form type
-
4
-
Filing time
-
21 Feb 2025, 13:28:44 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
LRCX |
Common Stock |
Options Exercise |
$679,690 |
+35,760 |
+20% |
$19.01 |
214,844 |
20 Feb 2025 |
Direct |
F1, F2 |
| transaction |
LRCX |
Common Stock |
Sale |
$3,218,400 |
-35,760 |
-17% |
$90.00 |
179,084 |
20 Feb 2025 |
Direct |
F1, F2 |
| transaction |
LRCX |
Common Stock |
Options Exercise |
$1,313,606 |
+74,320 |
+42% |
$17.68 |
253,404 |
20 Feb 2025 |
Direct |
F1, F2 |
| transaction |
LRCX |
Common Stock |
Sale |
$6,688,800 |
-74,320 |
-29% |
$90.00 |
179,084 |
20 Feb 2025 |
Direct |
F1, F2 |
| holding |
LRCX |
Common Stock |
|
|
|
|
|
2,367 |
20 Feb 2025 |
By 401(k) |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
LRCX |
Employee Stock Option (Right to Buy) |
Options Exercise |
$679,690 |
-35,760 |
-100% |
$19.01 |
0 |
20 Feb 2025 |
Common Stock |
35,760 |
$19.01 |
Direct |
F1, F3 |
| transaction |
LRCX |
Employee Stock Option (Right to Buy) |
Options Exercise |
$1,313,606 |
-74,320 |
-100% |
$17.68 |
0 |
20 Feb 2025 |
Common Stock |
74,320 |
$17.68 |
Direct |
F1, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: